Keratitis Sicca 

  • Author: Mark Ventocilla, OD, FAAO; Chief Editor: Hampton Roy Sr, MD   more...
 
Updated: Jan 4, 2012
 

Background

Keratitis sicca, or keratoconjunctivitis sicca (dry eye syndrome), is a relatively common inflammatory condition characterized by inadequate tear film protection of the cornea. There are multiple causes that produce either inadequate tear production or abnormal tear film constitution, resulting in excessively fast evaporation or premature destruction of the tear film.

There is no racial predilection for keratitis sicca; however, a female preponderance appears to exist. Sjögren syndrome (a triad of dry eye, dry mouth, and autoimmune connective-tissue disorder) is significantly more common in women (9:1), and milder forms of keratitis sicca also are more common in females than in males.

Patient education

Regular dental examinations are important because dry mouth, a component of Sjögren syndrome, significantly increases the risk of dental problems, and women should receive regular checkups from their gynecologists.

Patients with Sjögren syndrome can obtain up-to-date information from the following organization:

Sjögren’s Syndrome Foundation

6707 Democracy Boulevard

Suite 325

Bethesda, MD 20817

Phone: (301) 530-4420 or (800) 475-6473

Fax: (301) 530-4415

For patient education information, see Eye and Vision Center, as well as Dry Eye Syndrome, Pink Eye, and Sjögren's Syndrome.

See also the following:

Next

Pathophysiology

The tear film is constituted by 3 layers, as follows: (1) a lipid layer (0.11 µm thick), produced by the Meibomian glands of the upper and lower lid margin; (2) an aqueous layer (7.0 µm thick), produced by the main and accessory lacrimal glands of Krause and Wolfring; and (3) a hydrophilic mucin layer (0.02-0.05 µm thick), produced by the conjunctival goblet cells. Any abnormality of 1 of the 3 layers produces an unstable tear film and symptoms of keratitis sicca.

A tear layer frequently affected is the aqueous layer, resulting in aqueous tear deficiency (ATD) or lacrimal hyposecretion. A classification scheme stratifies patients with dry eye into those with aqueous tear deficiency and those with increased evaporative loss.

Patients with keratitis sicca have elevated levels of tear nerve growth factor (NGF); these levels were decreased with 0.1% prednisolone.[1] Data suggest that ocular surface nerve growth factor may play an important role in ocular surface inflammation processes associated with dry eyes.

Previous
Next

Etiology

The causes for keratitis sicca are multiple and can be multifactorial. They can be classified into 3 categories by the element of the tear layer that is mostly affected, as follows: (1) those affecting the aqueous tear layer, (2) those affecting the lipid tear layer, and (3) those affecting the mucin tear layer.

Causes of lipid tear layer abnormalities

The most common disorders associated with abnormalities of the lipid tear layer are blepharitis and rosacea. The severity of the dry eye symptoms appears to correlate to lipid layer thickness. It is now generally recognized that increased evaporation due to a compromised lipid layer is one of the most common etiologies for hyperosmolarity of the tear film.[2]

Causes of aqueous tear layer abnormalities

Idiopathic disease, congenital alacrima, and systemic vitamin A deficiency (xerophthalmia) are the most common conditions associated with aqueous tear deficiency.

Other etiologies include the following:

  • Lacrimal gland ablation
  • Sensory denervation
  • Collagen vascular diseases (eg, rheumatoid arthritis [RA], Wegener granulomatosis, and systemic lupus erythematosus [SLE])
  • Sjögren syndrome (see Sjögren Syndrome under Clinical)
  • Infiltration of the lacrimal glands by sarcoidosis or tumors
  • Postradiation fibrosis of the lacrimal glands
  • Conjunctival scarring as a result of ocular pemphigoid, Stevens-Johnson syndrome, trachoma, chemical/thermal burns, and atopic disease
  • Drug etiologies include oral contraceptives, antihistamines, beta-blockers, phenothiazine, and atropine

Causes of mucin tear layer abnormalities

The following are the most common conditions resulting in abnormalities of the mucin tear layer:

  • Vitamin A deficiency
  • Trachoma
  • Diphtheric keratoconjunctivitis
  • Mucocutaneous disorders
  • Topical medications
Previous
Next

Prognosis

The prognosis with keratitis sicca varies with the severity of the condition. Most patients have mild-to-moderate cases, and they can be treated symptomatically with lubricants, providing good relief of symptoms.

Patients with Sjögren syndrome or prolonged untreated dry eye represent a subgroup of patients with a worse prognosis and a more prolonged treatment regimen.

Complications

Significant punctate epitheliopathy can lead to corneal erosions, corneal ulceration (both sterile and infected), corneal neovascularization, corneal scarring, corneal thinning, and even corneal perforation.

Previous
 
 
Contributor Information and Disclosures
Author

Mark Ventocilla, OD, FAAO  Clinical Professor, Michigan College of Optometry; Editor, American Optometric Association Ocular Surface Society Newsletter; Chief Executive Officer, Elder Eye Care Group, PLC; President, Lakeshore Professional Eyecare, PC

Mark Ventocilla, OD, FAAO is a member of the following medical societies: American Academy of Optometry and American Optometric Association

Disclosure: Nothing to disclose.

Coauthor(s)

Marc R Bloomenstein, OD, FAAO  Director of Optometric Services, Schwartz Laser Eye Center; Adjunct Assistant Professor, Arizona College of Optometry; Adjunct Assistant Professor, Southern California College of Optometry

Marc R Bloomenstein, OD, FAAO is a member of the following medical societies: American Academy of Optometry, American Optometric Association, Arizona Optometric Association, and International Society of Cataract and Refractive Surgeons

Disclosure: Nothing to disclose.

Jacqueline Freudenthal, MD  Co-Investigator, Ophthalmic Consultants Centre, Toronto

Jacqueline Freudenthal, MD is a member of the following medical societies: American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, and Canadian Ophthalmological Society

Disclosure: Nothing to disclose.

Fernando H Murillo-Lopez, MD  Senior Surgeon, Unidad Privada de Oftalmologia CEMES

Fernando H Murillo-Lopez, MD is a member of the following medical societies: American Academy of Ophthalmology

Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD  Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

Additional Contributors

Simon K Law, MD, PharmD Associate Professor of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, David Geffen School of Medicine

Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Association for Research in Vision and Ophthalmology

Disclosure: Nothing to disclose.

Christopher J Rapuano, MD Professor, Department of Ophthalmology, Jefferson Medical College of Thomas Jefferson University; Director of the Cornea Service, Co-Director of Refractive Surgery Department, Wills Eye Institute

Christopher J Rapuano, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, Contact Lens Association of Ophthalmologists, Cornea Society, Eye Bank Association of America, International Society of Refractive Surgery, and Pan-American Association of Ophthalmology

Disclosure: Allergan Honoraria Speaking and teaching; Allergan Consulting fee Consulting; Alcon Honoraria Speaking and teaching; Inspire Honoraria Speaking and teaching; RPS Ownership interest Other; Vistakon Honoraria Speaking and teaching; EyeGate Pharma Consulting; Inspire Consulting fee Consulting; Bausch & Lomb Honoraria Speaking and teaching; Bausch & Lomb Consulting fee Consulting

References
  1. Lee HK, Ryu IH, Seo KY, Hong S, Kim HC, Kim EK. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients. Ophthalmology. Feb 2006;113(2):198-205. [Medline].

  2. Foulks GN. The correlation between the tear film lipid layer and dry eye disease. Surv Ophthalmol. Jul-Aug 2007;52(4):369-74. [Medline].

  3. Fujita M, Igarashi T, Kurai T, Sakane M, Yoshino S, Takahashi H. Correlation between dry eye and rheumatoid arthritis activity. Am J Ophthalmol. Nov 2005;140(5):808-13. [Medline].

  4. Geerling G, Tost FH. Surgical occlusion of the lacrimal drainage system. Dev Ophthalmol. 2008;41:213-29. [Medline].

  5. Barber LD, Pflugfelder SC, Tauber J, Foulks GN. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years. Ophthalmology. Oct 2005;112(10):1790-4. [Medline].

  6. Stonecipher K, Perry HD, Gross RH, Kerney DL. The impact of topical cyclosporine A emulsion 0.05% on the outcomes of patients with keratoconjunctivitis sicca. Curr Med Res Opin. Jul 2005;21(7):1057-63. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.